James Hollingshead Insulet Corp (PODD) insider trading activity

James Hollingshead is Former President and CEO of INSULET CORP. Currently has a direct ownership of 61,247 shares of PODD, which is worth approximately $18.3 Million. The most recent transaction as insider was on Apr 28, 2025, when has been sold 3,587 shares (Common Stock) at a price of $259.52 per share, resulting in proceeds of $930,898. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.2K

5.53% 3M change

47.23% 12M change

Total Value Held $18.3 Million

James Hollingshead Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2025	SELL Payment of exercise price or tax liability	$930,898 $259.52 p/Share	3,587 Reduced 5.53%	61,247 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$315,833 $272.27 p/Share	1,160 Reduced 1.76%	64,834 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$553,944 $267.09 p/Share	2,074 Reduced 3.05%	65,994 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	7,687 Added 10.15%	68,068 Common Stock
Feb 17 2025	SELL Payment of exercise price or tax liability	$5,055,410 $280.56 p/Share	18,019 Reduced 22.98%	60,381 Common Stock
Feb 17 2025	BUY Grant, award, or other acquisition	-	36,671 Added 31.87%	78,400 Common Stock
May 31 2024	SELL Payment of exercise price or tax liability	$703,975 $177.19 p/Share	3,973 Reduced 8.72%	41,599 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$148,548 $163.6 p/Share	908 Reduced 1.95%	45,572 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	12,303 Added 20.93%	46,480 Common Stock
Aug 28 2023	BUY Open market or private purchase	$1,006,825 $181.41 p/Share	5,550 Added 13.97%	34,177 Common Stock
Jun 01 2023	SELL Payment of exercise price or tax liability	$1,062,127 $272.48 p/Share	3,898 Reduced 11.98%	28,627 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	6,875 Added 17.49%	32,444 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	21,699 Added 45.91%	25,569 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	808 Added 17.27%	3,870 Common Stock

Also insider at

RSMDF

RESMED INC Healthcare

President, Sleep Business